← Open Payments lookup

LINDSAY MOFFETT: Open Payments

NPI 1851030464 · STAUNTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$577 in 10 payments from 8 companies in 2025. Trend: 2023 $426 · 2024 $610 · 2025 $577

Food & beverage: $577
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$130
Neurocrine BioSciences, Inc.2$129
Otsuka America Pharmaceutical, Inc.2$124
Vanda Pharmaceuticals Inc.1$103
Janssen Pharmaceuticals, Inc1$25
Lundbeck LLC1$24
E.R. Squibb & Sons, L.L.C.1$22
Otsuka Pharmaceutical Development & Commercialization, Inc.1$21

Products named: CAPLYTA, INGREZZA, REXULTI, FANAPT, INVEGA SUSTENNA, ABILIFY MAINTENA, COBENFY.

Industry payments across VA — which companies pay providers there.